PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
about
Technical challenges in the isolation and analysis of circulating tumor cellsProgrammed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patientsChromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis.Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancerA novel capillary nano-immunoassay for assessing androgen receptor splice variant 7 in plasma. Correlation with CD133 antigen expression in circulating tumor cells. A pilot study in prostate cancer patients.Liquid biopsy: ready to guide therapy in advanced prostate cancer?Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer.Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine.Emerging Variants of Castration-Resistant Prostate Cancer.Circulating Tumor Cells as Cancer Biomarkers in the Clinic.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Elucidating the mechanism of miRNA-214 in the regulation of gingival carcinomaAndrogen receptor expression on circulating tumor cells in metastatic breast cancer.Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer.Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters.Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level.Current treatment strategies for advanced prostate cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.Profiling Prostate Cancer Therapeutic Resistance.Liquid biopsy in pancreatic cancer: the beginning of a new era.Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer.Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
P2860
Q26741646-24D79943-6D62-4871-A27F-66E2C3B6963AQ36141581-06DC10C7-D241-436E-B0BB-34D02FC1F442Q36193912-8BFB20E6-73BE-456C-8FA6-EB576B90DEDEQ37550588-2490AE2D-F003-4C80-9DE1-1BA48CE97445Q37688197-E0B34729-BAEB-4D72-B5E5-9D5BE19FB97CQ37709148-E61AC168-9AA6-4C8A-9B93-F6A1EA01D8C0Q38732922-7B466C48-0AAB-4B1B-A786-A75686A190F6Q38840458-D0593952-94E3-4172-A84C-E47D5C1FB1ACQ38868832-5328016D-7C87-4B47-83A9-8D7CA827DAD5Q39132961-AF301727-90B2-46DF-A1A1-76A88BF18EEBQ39210257-6FE42379-2024-49B8-ABAC-B6E15BD75892Q39339875-BD70C2FC-D1A6-4B34-AFAB-134AC6748E07Q39438805-BC51ACBE-99E3-460D-B5DC-27E20718BFDDQ39454057-F2AC1339-3804-40BC-BF3A-060AB81D5206Q40423383-CB1F9E46-8401-4CFF-A5D7-EF1E935629EAQ40496979-E0AE26FD-AF12-44B8-9E06-EE9E8F3003AAQ42176783-81618AA3-1751-4DAC-A56E-6699DF6BC0E2Q42366191-241A80AA-823A-456B-8CCF-37D5BACC314FQ42700945-9739B117-BF73-4B02-A89F-ADF6DD165F00Q46855168-25264058-7F71-4FFC-9597-481A6B98CBD4Q47249769-AD1FA838-F75D-42C2-AE95-96255E32607CQ48561494-87AD3B8E-C61C-4842-BC4E-046093263809Q50199981-ACF61DF3-6767-459B-ADD0-AFE27A782EE6Q51311867-98A7A8FC-3ACA-45F6-BF33-70B2D79FFE71Q52644478-7F07AEDF-2849-4DD2-B511-1C1707DF2B66Q55187959-C570C292-FB21-42B1-B495-AA280C9686DBQ55343494-5542F10F-52A4-47BB-986B-99A0A863DD40Q57492447-CB0AF4D9-5EA0-4E53-ABB7-0DF8E8389F36
P2860
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PTEN loss in circulating tumou ...... stant prostate cancer patients
@ast
PTEN loss in circulating tumou ...... stant prostate cancer patients
@en
type
label
PTEN loss in circulating tumou ...... stant prostate cancer patients
@ast
PTEN loss in circulating tumou ...... stant prostate cancer patients
@en
prefLabel
PTEN loss in circulating tumou ...... stant prostate cancer patients
@ast
PTEN loss in circulating tumou ...... stant prostate cancer patients
@en
P2093
P2860
P356
P1476
PTEN loss in circulating tumou ...... stant prostate cancer patients
@en
P2093
Ajay Pandita
Aurelius Omlin
Carmel Pezaro
Daniel Nava Rodrigues
Dena Marrinucci
Edith Szafer-Glusman
Elizabeth A Punnoose
Eric K Tucker
Ines Figueiredo
Jessica Louw
P2860
P2888
P304
P356
10.1038/BJC.2015.332
P407
P577
2015-09-17T00:00:00Z